We are analyzing https://link.springer.com/article/10.1186/s13195-014-0082-1.

Title:
Prevalence of mixed pathologies in the aging brain | Alzheimer's Research & Therapy
Description:
The spectrum of mixed brain pathologies expands beyond accompanying vascular pathology in brains with Alzheimer’s disease-related pathology. Co-occurrence of neurodegenerative non-Alzheimer’s disease-type proteinopathies is increasingly recognized to be a frequent event in the brains of symptomatic and asymptomatic patients, particularly in older people. Owing to the evolving concept of neurodegenerative diseases, clinical and neuropathological diagnostic criteria have changed during the last decades. Autopsy-based studies differ in the selection criteria and also in the applied staining methods used. The present review summarizes the prevalence of mixed brain pathologies reported in recent community-based studies. In these cohorts, irrespective of the clinical symptoms, the frequency of Alzheimer’s disease-related pathology is between 19 and 67%, of Lewy body pathology is between 6 and 39%, of vascular pathologies is between 28 and 70%, of TDP-43 proteinopathy is between 13 and 46%, of hippocampal sclerosis is between 3 and 13% and, finally, of mixed pathologies is between 10 and 74%. Some studies also mention tauopathies. White-matter pathologies are not discussed specifically in all studies, although these lesions may be present in more than 80% of the aging brains. In summary, community-based neuropathology studies have shown that complex constellations of underlying pathologies may lead to cognitive decline, and that the number of possible combinations increases in the aging brain. These observations have implications for the prediction of the prognosis, for the development of biomarkers or therapy targets, or for the stratification of patient cohorts for genome-wide studies or, eventually, for therapy trials.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Education
Health & Fitness
Science

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 7,642,828 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

The income method remains a mystery to us.

Not every website is profit-driven; some are created to spread information or serve as an online presence. Websites can be made for many reasons. This could be one of them. Link.springer.com could be getting rich in stealth mode, or the way it's monetizing isn't detectable.

Keywords {🔍}

pubmed, article, google, scholar, study, pathologies, pathology, dementia, brain, cognitive, studies, aging, disease, cas, lewy, vascular, alzheimers, central, mixed, decline, tdp, bodies, neuropathol, prevalence, neuropathological, criteria, braak, frequent, neurodegenerative, older, table, neurol, lesions, reported, frequency, acta, schneider, including, clinical, protein, tau, neurology, patients, recent, body, impairment, consortium, alzheimer, research, communitybased,

Topics {✒️}

progressive supranuclear palsy vienna trans-danube aging tar-dna binding protein-43 de lucena ferretti-rebustini magnetic resonance imaging honolulu–asia aging study article download pdf late-onset amnestic dementias white-matter hyperintensities detected recent noncommunity-based studies small-vessel ischemic disease recent community-based studies community-based studies implement multiple system atrophy evaluated white-matter hyperintensities older community-dwelling subjects recent population-based study autopsy-based studies differ community-based autopsy series nia–aa criteria intermediate population-based studies varies jack cr jr cerebral amyloid angiopathy population-based cambridge city community-based neuropathology studies multiple system atrop p62/ubiquitin immunohistochemical screening recent clinical–pathologic research community-dwelling older persons community-based studies discussed demented japanese-american men assess ad-related pathology ad-related pathology starting post hoc test population-based neuropathologic study white-matter hyperintensities white matter hyperintensities aging–reagan criteria intermediate full size image mild ad-related pathology neurological symptoms leading privacy choices/manage cookies clinical–radiological–neuropathological studies radiologic–neuropathologic correlation study lewy body pathology including tangle-predominant dementia high-morbidity brain disease neurodegeneration-related proteins [3] neurodegeneration-related proteins ubiquitin-immunoreactive inclusions

Questions {❓}

Haller S, Kovari E, Herrmann FR, Cuvinciuc V, Tomm AM, Zulian GB, Lovblad KO, Giannakopoulos P, Bouras C: Do brain T2/FLAIR white matter hyperintensities correspond to myelin loss in normal aging?
Jellinger KA, Attems J: Is there pure vascular dementia in old age?
Launer LJ, Petrovitch H, Ross GW, Markesbery W, White LR: AD brain pathology: vascular origins?
MacQueen KM, McLellan E, Metzger DS, Kegeles S, Strauss RP, Scotti R, Blanchard L, Trotter RT: What is community?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Prevalence of mixed pathologies in the aging brain
         description:The spectrum of mixed brain pathologies expands beyond accompanying vascular pathology in brains with Alzheimer’s disease-related pathology. Co-occurrence of neurodegenerative non-Alzheimer’s disease-type proteinopathies is increasingly recognized to be a frequent event in the brains of symptomatic and asymptomatic patients, particularly in older people. Owing to the evolving concept of neurodegenerative diseases, clinical and neuropathological diagnostic criteria have changed during the last decades. Autopsy-based studies differ in the selection criteria and also in the applied staining methods used. The present review summarizes the prevalence of mixed brain pathologies reported in recent community-based studies. In these cohorts, irrespective of the clinical symptoms, the frequency of Alzheimer’s disease-related pathology is between 19 and 67%, of Lewy body pathology is between 6 and 39%, of vascular pathologies is between 28 and 70%, of TDP-43 proteinopathy is between 13 and 46%, of hippocampal sclerosis is between 3 and 13% and, finally, of mixed pathologies is between 10 and 74%. Some studies also mention tauopathies. White-matter pathologies are not discussed specifically in all studies, although these lesions may be present in more than 80% of the aging brains. In summary, community-based neuropathology studies have shown that complex constellations of underlying pathologies may lead to cognitive decline, and that the number of possible combinations increases in the aging brain. These observations have implications for the prediction of the prognosis, for the development of biomarkers or therapy targets, or for the stratification of patient cohorts for genome-wide studies or, eventually, for therapy trials.
         datePublished:2014-11-21T00:00:00Z
         dateModified:2014-11-21T00:00:00Z
         pageStart:1
         pageEnd:11
         license:http://creativecommons.org/publicdomain/zero/1.0/
         sameAs:https://doi.org/10.1186/s13195-014-0082-1
         keywords:
            Cognitive Decline
            Multiple System Atrophy
            Lewy Body
            Progressive Supranuclear Palsy
            Cerebral Amyloid Angiopathy
            Neurosciences
            Neurology
            Geriatrics/Gerontology
            Geriatric Psychiatry
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13195-014-0082-1/MediaObjects/13195_2014_Article_82_Fig1_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13195-014-0082-1/MediaObjects/13195_2014_Article_82_Fig2_HTML.jpg
         isPartOf:
            name:Alzheimer’s Research & Therapy
            issn:
               1758-9193
            volumeNumber:6
            type:
               Periodical
               PublicationVolume
         publisher:
            name:BioMed Central
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Jasmin Rahimi
               affiliation:
                     name:Medical University of Vienna
                     address:
                        name:Institute of Neurology, Medical University of Vienna, Vienna, Austria
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Gabor G Kovacs
               affiliation:
                     name:Medical University of Vienna
                     address:
                        name:Institute of Neurology, Medical University of Vienna, Vienna, Austria
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Prevalence of mixed pathologies in the aging brain
      description:The spectrum of mixed brain pathologies expands beyond accompanying vascular pathology in brains with Alzheimer’s disease-related pathology. Co-occurrence of neurodegenerative non-Alzheimer’s disease-type proteinopathies is increasingly recognized to be a frequent event in the brains of symptomatic and asymptomatic patients, particularly in older people. Owing to the evolving concept of neurodegenerative diseases, clinical and neuropathological diagnostic criteria have changed during the last decades. Autopsy-based studies differ in the selection criteria and also in the applied staining methods used. The present review summarizes the prevalence of mixed brain pathologies reported in recent community-based studies. In these cohorts, irrespective of the clinical symptoms, the frequency of Alzheimer’s disease-related pathology is between 19 and 67%, of Lewy body pathology is between 6 and 39%, of vascular pathologies is between 28 and 70%, of TDP-43 proteinopathy is between 13 and 46%, of hippocampal sclerosis is between 3 and 13% and, finally, of mixed pathologies is between 10 and 74%. Some studies also mention tauopathies. White-matter pathologies are not discussed specifically in all studies, although these lesions may be present in more than 80% of the aging brains. In summary, community-based neuropathology studies have shown that complex constellations of underlying pathologies may lead to cognitive decline, and that the number of possible combinations increases in the aging brain. These observations have implications for the prediction of the prognosis, for the development of biomarkers or therapy targets, or for the stratification of patient cohorts for genome-wide studies or, eventually, for therapy trials.
      datePublished:2014-11-21T00:00:00Z
      dateModified:2014-11-21T00:00:00Z
      pageStart:1
      pageEnd:11
      license:http://creativecommons.org/publicdomain/zero/1.0/
      sameAs:https://doi.org/10.1186/s13195-014-0082-1
      keywords:
         Cognitive Decline
         Multiple System Atrophy
         Lewy Body
         Progressive Supranuclear Palsy
         Cerebral Amyloid Angiopathy
         Neurosciences
         Neurology
         Geriatrics/Gerontology
         Geriatric Psychiatry
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13195-014-0082-1/MediaObjects/13195_2014_Article_82_Fig1_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13195-014-0082-1/MediaObjects/13195_2014_Article_82_Fig2_HTML.jpg
      isPartOf:
         name:Alzheimer’s Research & Therapy
         issn:
            1758-9193
         volumeNumber:6
         type:
            Periodical
            PublicationVolume
      publisher:
         name:BioMed Central
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Jasmin Rahimi
            affiliation:
                  name:Medical University of Vienna
                  address:
                     name:Institute of Neurology, Medical University of Vienna, Vienna, Austria
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Gabor G Kovacs
            affiliation:
                  name:Medical University of Vienna
                  address:
                     name:Institute of Neurology, Medical University of Vienna, Vienna, Austria
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Alzheimer’s Research & Therapy
      issn:
         1758-9193
      volumeNumber:6
Organization:
      name:BioMed Central
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Medical University of Vienna
      address:
         name:Institute of Neurology, Medical University of Vienna, Vienna, Austria
         type:PostalAddress
      name:Medical University of Vienna
      address:
         name:Institute of Neurology, Medical University of Vienna, Vienna, Austria
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Jasmin Rahimi
      affiliation:
            name:Medical University of Vienna
            address:
               name:Institute of Neurology, Medical University of Vienna, Vienna, Austria
               type:PostalAddress
            type:Organization
      name:Gabor G Kovacs
      affiliation:
            name:Medical University of Vienna
            address:
               name:Institute of Neurology, Medical University of Vienna, Vienna, Austria
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Institute of Neurology, Medical University of Vienna, Vienna, Austria
      name:Institute of Neurology, Medical University of Vienna, Vienna, Austria

External Links {🔗}(314)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

6.6s.

LINK . SPRINGER . COM {}